Lead-Related Venous Obstruction in Patients With Implanted Cardiac Devices

Zimetbaum, Peter; Carroll, Brett J.; Locke, Andrew H.; Secemsky, Eric A.; Schermerhorn, Marc L.

doi:10.1016/j.jacc.2021.11.017

Cited by 16 publications

(12 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For occlusions that are relatively acute or subacute (within weeks to months) with relatively fresh thrombus, debulking strategies, including the local administration of thrombolytics or the use of venous thrombus extraction devices, should be considered. If leads are reimplanted or left in place, lifelong anticoagulation is recommended [2]. Fortunately, the patient had complete resolved nine months later and has been taking adequate rivaroxaban anticoagulant.…”

Section: Discussionmentioning

confidence: 99%

“…most patients are asymptomatic because of the progressive formation of collateral veins. However, in recent decades, thrombotic occlusion of SVC is frequently encountered because of presence of central venous catheters and pacemaker leads [1,2]. Treatment options for lead-related venous occlusion are mainly supported by case series and anecdotal experience [2].…”

Section: Introductionmentioning

confidence: 99%

“…However, in recent decades, thrombotic occlusion of SVC is frequently encountered because of presence of central venous catheters and pacemaker leads [1,2]. Treatment options for lead-related venous occlusion are mainly supported by case series and anecdotal experience [2]. We report a case of an 80-year-old man who presented with SVC syndrome after transvenous pacemaker implantation with symptoms basically relieved after 4 months of direct oral anticoagulants (DOACs).…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Treatment of pacemaker-induced superior vena cava syndrome by direct oral anticoagulant

Huang

Chen

Liu

et al. 2022

Preprint

View full text Add to dashboard Cite

Background The use of cardiac implantable electronic device have grown substantially over the past two decades, lead related vascular issues are commonly encountered in clinical practice. Superior vena cava (SVC) syndrome due to pacemaker leads is an uncommon complication. Anticoagulation currently remains the mainstay of therapy to restore some degree of patency and relieve swelling. However, there is very limited clinical trials on direct oral anticoagulants (DOACs) . Case presentation: We report a case of a 80-year-old man who developed SVC syndrome after transvenous pacemaker implantation with symptoms of obstruction were significantly relieved after four months of DOACs. His symptoms had complete resolved nine months later. Conclusions DOACs are effective in the treatment of SVC syndrome after pacemaker implantation, representing an important new approach. It is a very good choice for patients who do not want to undergo interventional therapy.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Treatment of pacemaker-induced superior vena cava syndrome by direct oral anticoagulant

Huang

Chen

Liu

et al. 2022

Preprint

View full text Add to dashboard Cite

show abstract

“…Most patients are asymptomatic because of the progressive formation of collateral veins. However, in recent decades, thrombotic occlusion of SVC is frequently encountered because of the presence of central venous catheters and pacemaker leads [ 1 , 2 ]. Treatment options for lead-related venous occlusion are mainly supported by case series and anecdotal experience [ 2 ].…”

Section: Introductionmentioning

confidence: 99%

“…However, in recent decades, thrombotic occlusion of SVC is frequently encountered because of the presence of central venous catheters and pacemaker leads [ 1 , 2 ]. Treatment options for lead-related venous occlusion are mainly supported by case series and anecdotal experience [ 2 ]. We report a case of an 80-year-old man who presented with SVC syndrome after transvenous pacemaker implantation with symptoms relieved after 4 months of direct oral anticoagulants (DOACs).…”

Section: Introductionmentioning

confidence: 99%

Treatment of pacemaker-induced superior vena cava syndrome by direct oral anticoagulant

et al. 2023

View full text Add to dashboard Cite

Background The use of cardiac implantable electronic devices has grown substantially over the past two decades, lead-related vascular issues are commonly encountered in clinical practice. Superior vena cava (SVC) syndrome due to pacemaker leads is an uncommon complication. Anticoagulation remains the mainstay of therapy to restore some degree of patency and relieve swelling. However, there are limited clinical trials on direct oral anticoagulants (DOACs). Case presentation We report a case of an 80-year-old man who developed SVC syndrome after transvenous pacemaker implantation with symptoms of obstruction that were significantly relieved after four months of DOACs. His symptoms had completely resolved nine months later. Conclusions DOACs are effective in the treatment of SVC syndrome after pacemaker implantation, representing an important new approach. It is a very good choice for patients who do not want to undergo interventional therapy.

show abstract

Sex differences in outcomes of transvenous lead extraction: insights from National Readmission Database

Khalil

Maqsood

Maraey

et al. 2022

J Interv Card Electrophysiol

View full text Add to dashboard Cite

Lead-Related Venous Obstruction in Patients With Implanted Cardiac Devices

Cited by 16 publications

References 38 publications

Treatment of pacemaker-induced superior vena cava syndrome by direct oral anticoagulant

Treatment of pacemaker-induced superior vena cava syndrome by direct oral anticoagulant

Treatment of pacemaker-induced superior vena cava syndrome by direct oral anticoagulant

Sex differences in outcomes of transvenous lead extraction: insights from National Readmission Database

Contact Info

Product

Resources

About